Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial.

Publication date: Jan 26, 2025

Safety and immunogenicity assessment of updated monovalent and bivalent SARS-CoV-2 vaccines in adolescents. This phase 3, double-blinded study randomised 12-

Concepts Keywords
Adolescents booster
Mrna COVID-19
Randomised SARS-CoV-2
Vaccinated variant
Vaccines

Semantics

Type Source Name
disease IDO protein
disease MESH COVID-19

Original Article

(Visited 2 times, 1 visits today)